The world’s biggest generic pharmaceutical companies in 2018
  • Vote Up0Vote Down venynxvenynx
    Posts: 2,389Member

    Mylan emerged as the world’s biggest generic pharmaceutical company
    in 2018 despite a decline in net sales, as the industry peers face
    turbulence due to price erosion and pricing regulations.
    Pharmaceutical-technology.com lists the world’s biggest generic drug
    sellers based on revenues from January to December 2018. Except Teva
    Pharmaceuticals and Sanofi, none others from the top ten list currently
    market patented drugs.Raloxifene powder



    Sanofi’s generics business posted net sales of $1.69bn in 2018, which
    was a decline of 9.8% compared to the preceding year. The reduction was
    primarily due to the divestment of the company’s European generic
    business, Zentiva, in the second half of the year. The divestment was
    aimed at reorienting and streamlining the company’s operations.



    The company’s net sales from generics increased by 3.8% in the
    emerging markets. The company also witnessed lower sales in the US and
    European regions, which was offset by higher sales in the
    rest-of-the-world (ROW) region, especially in Japan.



    Sanofi launched a generic powder form of Renvela® in the US market
    during the year. Renvela® is indicated to control serum phosphorus in
    patients with chronic kidney disease undergoing dialysis.



    Based in France, Sanofi is a pharmaceutical company with business
    organised under five global units, including general medicines and
    emerging markets, speciality care, vaccines, consumer healthcare, and
    diabetes and cardiovascular.The global generics segment of Dr. Reddy’s
    accounted for approximately 80% of the company’s revenue in 2018, with
    North America being the biggest contributor.



    As of March 2018, the company filed 20 abbreviated new drug
    applications (ANDAs) and had 110 generic filings pending for approval
    with the US FDA. It also launched five first-generic-to-launch (FGTL)
    products in Brazil.



    Based in India, Dr. Reddy’s is a pharmaceutical company whose generic
    formulations business offers more than 200 high-quality generic drugs
    worldwide with over 20 assets falling under the complex generics
    category, including decitabine, fondaparinux, and azacitidine
    injections.



    The company’s generic formulations segment includes tablets,
    capsules, injectables, and topical creams. Omez (Omeprazole), Nise
    (Nimesulide), Stamlo (Amlodipine Besylate), and Razo (Rabeprazole) are
    some of its products available in the emerging markets.

Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Top Posters

Who's Online (0)